* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download METHODS TO STUDY DRUG SAFETY PROBLEMS
Survey
Document related concepts
Drug discovery wikipedia , lookup
Pharmacognosy wikipedia , lookup
Drug design wikipedia , lookup
Pharmaceutical marketing wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Electronic prescribing wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Patent medicine wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Drug interaction wikipedia , lookup
Prescription costs wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Transcript
METHODS TO STUDY DRUG SAFETY PROBLEMS • animal experiments • clinical trials • epidemiological methods – spontaneous reporting • case reports • case series – Post-Marketing Surveillance (PMS) – prescription event monitoring – cohort studies • intensive hospital monitoring – case - control studies – record-linkage • meta-analysis Spontaneous reporting Principle The alert health professional connects an undesirable medical event with drug exposure (SUSPICION) Reports suspicion to information collecting centre ADVERSE DRUG REACTION WHO definition • A reaction which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological function ADVERSE EVENT/EXPERIENCE WHO definition • Any untoward medical occurrence that may present during treatment with a pharmaceutical product but which does not necessarily have a causal relationship with this treatment SPONTANEOUS REPORTING • Advantages – large population – – – – – all medicines hospital and out-patient care long perspective patient analyses possible inexpensive SPONTANEOUS REPORTING • Disadvantages – underreporting Reporting varies with: • • • • • severity of reaction time from market introduction promotional claims promotion of reporting system publicity of specific association SPONTANEOUS REPORTING • Disadvantages – underreporting – difficult to detect • delayed reactions • reactions with high background incidence – important details often missing – number of exposed unknown – bias When to report? Early phase • Simple message : – Report as soon as you suspect that drug therapy has resulted in a negative, unintended effect. • i.e all suspected reactions • Speed is essential What to report? • Adverse reactions – Type A – Type B • Lack of effect • • • • – counterfeiting – resistance – interaction Quality problem Dependence and abuse Poisoning (?) Medical error (?) What to report? • Allopathic medicines – Prescription – OTC • Traditional medicines • Biologicals incl vaccines What to report? Alternative approach • • • • Serious reactions (definitions available) Unexpected reaction (not in product info) Unusually severe reactions New medicines